Search - tctmd.com

Displaying 61 - 80 of 207

Sort: Relevancy | Date

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Daily News

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

Caitlin E. Cox

September 20, 2019

News Daily News

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Yael L. Maxwell

August 15, 2019

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Todd Neale

July 04, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Michael O'Riordan

April 15, 2019

News Industry News

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

April 10, 2019

News Daily News

Direct Admission to PCI-Capable Center Linked With Lower All-Cause Mortality

Michael O'Riordan

March 06, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

Yael L. Maxwell

September 21, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Industry News

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

May 24, 2018

News Industry News

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

May 23, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Industry News

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

February 26, 2018

Advertisement

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

TCTMD’s Top 10 Most Popular Stories for June 2019

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

Direct Admission to PCI-Capable Center Linked With Lower All-Cause Mortality

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content